Newsfeeds Archive - Spark Newswire

2 minute read

Fresenius SE’s Future With Dialysis Company Unclear, Investors Seek Answers

May 17, 1:13 PM

Investors urge Fresenius SE to clarify its strategic plans for Fresenius Medical Care after recent deconsolidation. Despite holding a 32% stake, challenges like high dialysis patient mortality and nursing shortages impact both companies' performance and share value.

BAX

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights

May 7, 8:06 AM

Gainers FibroGen (NASDAQ:FGEN) shares rose 37.1% to $1.59 during Tuesday’s pre-market session. The market value of their outstanding…

CLLS

1 minute read

AudioCodes Reports Downbeat Earnings, Joins Trupanion, Palantir Technologies And Other Big Stocks Moving Lower In Tuesday Pre-Market Session

By Avi Kapoor

May 7, 5:33 AM

U.S. stock futures were mostly higher this morning, with the Dow futures gaining around 80 points on Tuesday.…

AUDC

2 minute read

Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday

By Avi Kapoor

April 22, 10:10 AM

U.S. stocks were higher, with the Nasdaq Composite gaining over 100 points on Monday. Shares of Matterport, Inc.…

ANL

2 minute read

Dialysis Player Fresenius Medical’s Q4 Sales Hold Steady: Details

By Vandana Singh

February 20, 2:17 PM

Fresenius Medical Care Q4 2023 revenue: €4.9 billion. Patient volume growth is expected at 0.5%-2% in 2024.

DVA

9 minute read

Earnings

Earnings Scheduled For February 20, 2024

By Benzinga Insights

February 20, 7:52 AM

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion.

ABCL

1 minute read

Earnings

Fresenius Medical Care: Q4 Earnings Insights

By Benzinga Insights

February 20, 7:00 AM

Fresenius Medical Care (NYSE:FMS) reported its Q4 earnings results on Tuesday, February 20, 2024 at 02:00 AM. Here’s…

FMS

1 minute read

Earnings

A Preview Of Fresenius Medical Care’s Earnings

By Benzinga Insights

February 19, 10:01 AM

Fresenius Medical Care (NYSE:FMS) is set to give its latest quarterly earnings report on Tuesday, 2024-02-20. Here’s what…

FMS

2 minute read

News

Fresenius Medical Care Executes On Its Strategic Portfolio Optimization Program And Announces Key Transactions

By Benzinga Newsdesk

January 8, 9:37 AM

Divestments in 2023 are important milestones of the Company's execution against its Portfolio Optimization which are part of the set strategic aspirationsDelivers on commitment to improve leverage ratio by allocating

FMS

1 minute read

News

Fresenius Majority-Owned Group Mabxience Has Licensing Agreement With Intas Pharmaceuticals for Autoimmune Disease Drug Etanercept

By Charles Gross

December 20, 6:02 AM

Intas Pharmaceuticals Ltd., a leading multinational pharmaceutical company, has announced today a strategic exclusive licensing agreement with mAbxience (a Fresenius Kabi majority-owned group with partial

FMS